Genetic testing company 23andMe Inc. will comply with a Food and Drug Administration directive to stop selling health-related genetic tests during a regulatory review.
About 61,000 Washington residents have signed up for private insurance through the state's new health care exchange since it opened on Oct. 1. But 43,000 of them need to finish enrolling by paying for their new health coverage that is set to begin in January.
Idaho will let insurance carriers reinstate coverage for thousands of people who were due to have policies canceled under President Barack Obama's health care overhaul.
California formally launched its insurance exchange for small businesses Monday as questions loom about potentially higher rates and just days after the federal government said it was shelving its version of the online portal for a year.
A judge said Monday that he'll announce next week whether Detroit is eligible to overhaul itself in bankruptcy court, the most important decision since the largest public filing in U.S. history last summer.
Washington state's Medicaid program that gives free health insurance to the poor is working with the federal government on an experiment that is expected to save taxpayer dollars and improve services.
The Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.